Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Sign Up to like & getrecommendations! Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-019-14122-0
Abstract: Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis, but this has not been tested directly in vivo. Here, we investigated synaptic vesicle glycoprotein 2A (SV2A) levels and their relationship to symptoms… read more here.
Keywords: density marker; sv2a reduced; reduced schizophrenia; sv2a ... See more keywords